CDC endorses expanded COVID-19 booster rollout for millions

Millions of Americans are now eligible for COVID-19 booster shots after the CDC's advisory panel endorsed additional doses for recipients of all three vaccines—Pfizer, Moderna, and Johnson & Johnson—while allowing the option to mix and match brands. This decision follows the FDA's authorization and aims to provide flexibility, particularly for individuals who may be at risk for specific vaccine-related side effects. The CDC has outlined eligibility for the booster, particularly for those aged 65 and older, nursing home residents, and other high-risk groups. Meanwhile, Johnson & Johnson's vaccine has been noted to require a booster sooner due to its lower effectiveness compared to Pfizer and Moderna. The FDA's advisory panel has also indicated that all vaccines continue to offer significant protection against severe illness, but the focus remains on vaccinating the unvaccinated population. Current discussions around the topic highlight the importance of ensuring access to boosters while addressing safety concerns regarding the vaccines.